Volume | 114,913 |
|
|||||
News | - | ||||||
Day High | 1.07 | Low High |
|||||
Day Low | 1.04 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Enzo Biochem Inc | ENZ | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.07 | 1.04 | 1.07 | 1.05 | 1.07 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
656 | 114,913 | US$ 1.05 | US$ 120,498 | - | 1.04 - 2.74 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:00:00 | 607 | US$ 1.05 | USD |
Enzo Biochem Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
53.79M | 51.23M | - | 31.06M | 20.29M | 0.40 | 2.65 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Enzo Biochem News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ENZ Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.11 | 1.115 | 1.04 | 1.08 | 121,147 | -0.06 | -5.41% |
1 Month | 1.29 | 1.30 | 1.04 | 1.16 | 110,075 | -0.24 | -18.60% |
3 Months | 1.24 | 1.40 | 1.04 | 1.26 | 112,927 | -0.19 | -15.32% |
6 Months | 1.39 | 1.50 | 1.04 | 1.29 | 108,320 | -0.34 | -24.46% |
1 Year | 2.45 | 2.74 | 1.04 | 1.54 | 168,690 | -1.40 | -57.14% |
3 Years | 3.27 | 4.15 | 1.00 | 2.40 | 230,227 | -2.22 | -67.89% |
5 Years | 3.50 | 5.50 | 1.00 | 2.83 | 363,804 | -2.45 | -70.00% |
Enzo Biochem Description
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment. |